GlassScriptPhysician profile
Charles C Cox
NPI 1306307855
$3,901.29
in general payments reported to CMS, 2019-2025
20 companies · $655 in 2025
The $655 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.47 · 2021: $26.03 · 2022: $71.43 · 2023: $2,071 · 2024: $1,060 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,517 · Education: $1,305 · Travel and Lodging: $964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,516.77 |
| Education | $1,305.00 |
| Travel and Lodging | $963.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,094.63 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Ethicon US, LLC | $384.67 | 2025 | N/A, Echelon Flex, Harmonic |
| Medical Device Business Services, INC. | $305.00 | 2024 | |
| Davol INC. | $293.94 | 2023-2025 | Phasix Mesh |
| Tela Bio, INC. | $161.93 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $150.70 | 2021-2025 | Tisseel |
| W. L. Gore & Associates, INC. | $120.91 | 2024 | Gore Synecor Biomaterial |
| Kerecis Limited | $99.21 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Merck Sharp & Dohme LLC | $58.36 | 2022-2024 | Zerbaxa, Recarbrio, Dificid |
| Medtronic, INC. | $43.34 | 2023-2025 | Maxtack, Sonicision |
| Abbvie INC. | $23.76 | 2023 | Alloderm |
| Takeda Pharmaceuticals U.S.A., INC. | $22.12 | 2023 | Gattex |
| Trevena, INC. | $19.74 | 2023 | Olinvyk |
| Eisai INC. | $19.58 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.47 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $18.46 | 2022 | |
| Shionogi INC | $18.29 | 2023 | Fetroja |
| Novo Nordisk INC | $18.10 | 2025 | |
| Standard Bariatrics, INC. | $16.33 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.75 | 2024 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.